QDEL - QuidelOrtho evaluating sale of transfusion medicine business - report
2023-11-15 16:56:29 ET
More on Quidel
- QuidelOrtho Corporation (QDEL) Q3 2023 Earnings Call Transcript
- QuidelOrtho Corporation 2023 Q3 - Results - Earnings Call Presentation
- QuidelOrtho: Growth Problems Persist Due To Pandemic Wind Down
- Quidel Non-GAAP EPS of $0.90 beats by $0.34, revenue of $744M beats by $51.72M
- Seeking Alpha’s Quant Rating on Quidel
For further details see:
QuidelOrtho evaluating sale of transfusion medicine business - report